Prescription drug monitoring program inquiry in psychiatric assessment: Detection of high rates of opioid prescribing to a dual diagnosis population

Journal of Clinical Psychiatry

Volumn 75, Issue 7, 2014, Pages 750-756

  Hackman, Daniel T ^a   Greene, Marion S ^b   Fernandes, Taya J ^c   Brown, Ashley M ^c   Wright, Eric R ^b   Chambers, R Andrew ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INSPECT Indiana Professional Licensing Agency   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABINOID; CANNABIS; COCAINE; CODEINE; CONTROLLED SUBSTANCE; HYDROCODONE; HYPNOTIC AGENT; KETAMINE; METHADONE; MODAFINIL; MORPHINE; NICOTINE; OPIATE; OPIATE DERIVATIVE; OXYCODONE; PREGABALIN; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CAUCASIAN; COCAINE DEPENDENCE; COMMUNITY MENTAL HEALTH CENTER; DATA ANALYSIS; DEMOGRAPHY; DRUG ABUSE; DRUG DATABASE; DRUG DEPENDENCE; DRUG SURVEILLANCE PROGRAM; DSM-IV; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; MOOD DISORDER; OPIATE ADDICTION; PERSONALITY DISORDER; PILL; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; TOBACCO DEPENDENCE;

ADULT; ANALGESICS, OPIOID; CONTROLLED SUBSTANCES; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84905237614     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09020     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492. PubMed
2. Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(suppl):ES9-ES38. PubMed
3. Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry. 2011;72(5):589-592. doi:10.408/JCP.10com06560 PubMed
4. IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2011 http://www.environmentalhealthnews.org/ehs/news/ 2013/pdf-links/IHII-Medicines-in-U.S-Report-2011-1.pdf. Updated April 2012. Accessed April 14, 2014.
5. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses-a US epidemic. MMWR Morb Mortal Wkly Rep. 2012;61(1):10-13. PubMed
6. Governale L. Outpatient prescription opioid utilization in the US, years 2000-2009. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/ UCM220950.pdf. Updated July 22, 2010. Accessed April 14, 2014
7. Deyo RA, Smith DH, Johnson ES, et al. Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med. 2011;24(6):717-727. doi:10.312/jabfm.201.06.10232 PubMed
8. Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician. 2007;10(3):479-491. PubMed (Pubitemid 46971301)
9. Katz N, Houle B, Fernandez KC, et al. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. Pain Med. 2008;9(5):587-594. doi:10.1/j.1526-4637.208.0471.x PubMed
10. Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56(1):19-23, e1-3. doi:10.1016/j.anemergmed.209.12.01 PubMed
11. Sullivan MD, Edlund MJ, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166(19):2087-2093. doi:10.101/archinte.16.19.2087 PubMed (Pubitemid 44631396)
12. Bohnert AS, Ilgen MA, Ignacio RV, et al. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry. 2012;169(1):64-70. doi:10.176/api.ajp.201.10101476 PubMed
13. Richardson LP, Russo JE, Katon W, et al. Mental health disorders and longterm opioid use among adolescents and young adults with chronic pain. J Adolesc Health. 2012;50(6):553-558. doi:10.1016/j.jadohealth.201.1.01 PubMed
14. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940-947. doi:10.101/jama.2012.234 PubMed
15. Becker WC, Fiellin DA, Gallagher RM, et al. The association between chronic pain and prescription drug abuse in Veterans. Pain Med. 2009;10(3):531-536. doi:10.1/j.1526-4637.209.0584.x PubMed
16. Meghani SH, Wiedemer NL, Becker WC, et al. Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program. Pain Med. 2009;10(5):858-865. doi:10.1/j.1526-4637.209. 0643.x PubMed
17. Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105(10):1776-1782. doi:10.1/j.1360-043.2010.03052.x PubMed
18. Edlund MJ, Martin BC, Fan MY, et al. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010;112(1-2):90-98. doi:10.1016/j.drugalcdep.2010. 05.017 PubMed
19. Edlund MJ, Martin BC, Devries A, et al. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26(1):1-8. doi:10.1097/AJP. 0b013e3181b9f35 PubMed
20. Sullivan MD. Who gets high-dose opioid therapy for chronic non-cancer pain? Pain. 2010;151(3):567-568. doi:10.1016/j.pain.2010.08.036 PubMed
21. Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry. 2001;50(2):71-83. doi:10.1016/S06-323(01)0134-9 PubMed (Pubitemid 32728207)
22. Chambers RA. Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders. Drug Alcohol Depend. 2013;130(1-3):1-12. doi:10.1016/j.drugalcdep.2012.12.05 PubMed
23. Feldman L, Skeel Williams K, Knox M, et al. Influencing controlled substance prescribing: attending and resident physician use of a state prescription monitoring program. Pain Med. 2012;13(7):908-914. doi:10.1/j.1526-4637.2012.01412.x PubMed
24. Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf. 2010;19(2):115-123. doi:10.102/pds.1878 PubMed
25. Menard S. Applied Logistic Regression Analysis. 2nd ed. London, UK: Sage;
26. Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010;59(23):705-709. PubMed
27. Paulozzi LJ. Prescription drug overdoses: a review. J Safety Res. 2012;43(4):283-289. doi:10.1016/j.jsr.2012.08.09 PubMed
28. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1-2):8-18. doi:10.1016/j.drugalcdep.2012.07.04 PubMed
29. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry. 2004;56(10):730-737. doi:10.1016/j.biopsych.204.06.034 PubMed (Pubitemid 39539830)
30. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606-2610. doi:10.101/jama.284.20.2606 PubMed
31. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the NCS. Arch Gen Psychiatry. 1994;51(1):8-19. doi:10.101/archpsyc.194.0395010802 PubMed (Pubitemid 24028993)
32. Grant BF. Prevalence and correlates of alcohol use and DSM-IV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1996;8:195-210. doi:10.1016/S089-3289(96) 90249-7 PubMed (Pubitemid 26312779)
33. Grant BF. Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol. 1997;58:464-473. PubMed (Pubitemid 27344166)
34. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(11):1107-1115. doi:10.101/archpsyc.61.1.107 PubMed (Pubitemid 39463411)
35. Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatry. 2005;162(10):1911-1918. doi:10.176/api.ajp.162.10.191 PubMed (Pubitemid 41428621)
36. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295-302. doi:10.176/api.ajp.158.2.295 PubMed (Pubitemid 32116528)
37. Lieb K, Zanarini MC, Schmahl C, et al. Borderline personality disorder. Lancet. 2004;364(9432):453-461. doi:10.1016/S0140-6736(04)1670-6 PubMed (Pubitemid 39036894)
38. Centers for Disease Control and Prevention (CDC). Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. MMWR Morb Mortal Wkly Rep. 2009;58(42):1171-1175. PubMed
39. Inciardi JA, Surratt HL, Kurtz SP, et al. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007;8(2):171-183. doi:10.1/j.1526-4637.206.025.x PubMed
40. Inciardi JA, Surratt HL, Cicero TJ, et al. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009;10(3):537-548. doi:10.1/j.1526-4637.209.0603.x PubMed
41. Chambers RA, Connor MC, Boggs CJ, et al. The Dual Diagnosis Physician-infrastructure Assessment Tool: examining physician attributes and dual diagnosis capacity. Psychiatr Serv. 2010;61(2):184-188. doi:10.176/api.ps.61.2.184 PubMed
42. Chambers RA. The addiction psychiatrist as dual diagnosis physician: a profession in great need and greatly needed. J Dual Diagn. 2013;9(3):260-266.